ARQT Arcutis Biotherapeutics, Inc.
Healthcare$20.86-0.71%ClosedMarket Cap: $2.61B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$35.50
Target (Median)
$35.50
Target Range
$34.00 - $37.00
Upside from current price: 70.2%
Rating Distribution
2 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-07 | Needham | maintain | Buy | Buy |
| 2026-03-02 | Mizuho | maintain | Outperform | Outperform |
| 2026-02-27 | Guggenheim | maintain | Buy | Buy |
| 2026-02-26 | Needham | maintain | Buy | Buy |
| 2026-02-26 | TD Cowen | maintain | Buy | Buy |
| 2026-02-26 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-26 | Needham | maintain | Buy | Buy |
| 2025-11-28 | Mizuho | maintain | Outperform | Outperform |
| 2025-10-30 | Goldman Sachs | maintain | Neutral | Neutral |
| 2025-10-28 | Needham | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $1.07 | $645.2M | 5 |
| Sun Dec 31 | $1.84 | $782.6M | 6 |
| Mon Dec 31 | $2.48 | $919.7M | 4 |
| Tue Dec 31 | $2.90 | $1.06B | 2 |